K. Ding

Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer

M. Buyse, W. Parulekar, P. Roy, 2015, British Journal of Cancer.

Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials

T. Whelan, K. Gelmon, J. Ingle, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

The economic impact of the transition from branded to generic oncology drugs.

Bingshu E. Chen, K. Ding, D. Tu, 2016, Current oncology.

Innovative estimation of survival using log-normal survival modelling on ACCENT database

D. Sargent, P. Catalano, R. Gray, 2013, British Journal of Cancer.

l -Arginine and Its Transporters in Colorectal Cancer

Guowang Xu, Hai Hu, P. Gao, 2017 .

Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: the JBR.10 trial experience.

L. Seymour, R. Livingston, K. Ding, 2007, Lung cancer.

Comparison of innovative estimation of efficacy to standard using the ACCENT database.

D. Sargent, P. Catalano, R. Gray, 2011, Journal of Clinical Oncology.